Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
230
Views
34
CrossRef citations to date
0
Altmetric
Review

Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy

Paola Faverio1 School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy, [email protected];2 Respiratory Unit, San Gerardo Hospital, ASST di Monza, Monza, Italy, [email protected]Correspondence[email protected]
,
Giulia Bonaiti1 School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy, [email protected];2 Respiratory Unit, San Gerardo Hospital, ASST di Monza, Monza, Italy, [email protected]
,
Francesco Bini3 ASST-Rhodense, UOC Pneumologia, Garbagnate Milanese, Milan, Italy
,
Adriano Vaghi3 ASST-Rhodense, UOC Pneumologia, Garbagnate Milanese, Milan, Italy
&
Alberto Pesci1 School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy, [email protected];2 Respiratory Unit, San Gerardo Hospital, ASST di Monza, Monza, Italy, [email protected]
Pages 2385-2396 | Published online: 07 Dec 2018

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.